Search
01/05/2026
Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarction: A clinical consensus statement of the ESC Working Group on Cardiovascular Surgery, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function, the European Association of Preventive Cardiology of the ESC, the Heart Failure Association of the ESC, the European Association of Cardiovascular Imaging of the ESC, and the European Association for Cardio-Thoracic Surgery
Lorusso, R, Matteucci, M, Ronco, D, Massimi, G, Price, S, Czerny, M, Estévez-Loureiro, R, Siepe, M, Pontone, G, Hassager, C, Chioncel, O, Zuin, M, Davos, CH, Adamo, M, Gustafsson, F, Giannakoulas, G, Amabile, N, Sionis, A, Thielmann, M, Petersen, SE, Cosyns, B, Huber, K, Tokmakova, M, Pacini, D, Klok, FA, Saia, F, Abreu, A, Grimm, M, Claeys, MJ, García-Alvarez, A, Gerber, B, Mestres, CA, Rosenkranz, S, Adamopoulos, S, Bonaros, N. Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarction: A clinical consensus statement of the ESC Working Group on Cardiovascular Surgery, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function, the European Association of Preventive Cardiology of the ESC, the Heart Failure Association of the ESC, the European Association of Cardiovascular Imaging of the ESC, and the European Association for Cardio-Thoracic Surgery. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2026; 68(5)DOI:10.1093/ejcts/ezag157. PMID:42112794. IF:3.000(Q1/2D).
01/05/2026
EOSINOPHILIC MYOCARDITIS INTERNATIONAL REGISTRY
Palazzini, M, Lehtonen, J, Potena, L, Mäyränpää, M, Rågback, J, Foà, A, Uribarri, A, Thiele, H, Vidal-burdeus, M, Freund, A, Gustafsson, F, Tschöpe, C, Elsanhoury, A, Ihle, J, Rudi, W, Grabmaier, U, Merlo, M, Melenovsky, V, Weislova, I, Jellinghaus, S, Linke, A, Baldovini, C, Adorisio, R, Kuchynka, P, Palecek, T, Krejcí, J, Poloczková, H, Caterino, A, Gilotra, N, Lovell, J, Macomb, E, Shih, J, Hong, K, Rossi, V, Ruschitzka, F, Cavallini, C, Riccini, C, Kamal, M, Huang, F, Groh, M, Gentile, P, Andrea, G, Lala, A, Shimokawa, H, Vandenbriele, C, Sionis, A, Schmidt, M, Grosu, A, Bollano, E, Turco, A. EOSINOPHILIC MYOCARDITIS INTERNATIONAL REGISTRY. EUROPEAN HEART JOURNAL SUPPLEMENTS. 2026; 28DOI:10.1093/eurheartjsupp/suag058.401. PMID:. IF:2.500(Q2/5D).
01/05/2026
Differential regulation of the HIF-1«/apoptosis axis by miR-126-5p in cardiac cells during ischemia/reperfusion injury
Ramos-Regaladoa, L, Schoch, L, Alcovera, S, Magaldi, M, Barriusoa, I, Padróa, T, Borrella, M, Badimona, L, Zaragozad, C, Vilahura, G. Differential regulation of the HIF-1«/apoptosis axis by miR-126-5p in cardiac cells during ischemia/reperfusion injury. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2025.500842. PMID:40816967. IF:(Q/D).
01/05/2026
Effect of type-2 diabetes on surface lipids and biophysical properties in lipoprotein populations
Reis, A, Araújo, ARD, Dias, IH, Antonny, B, Perez, A, Sánchez-Quesada, JL, de Freitas, V. Effect of type-2 diabetes on surface lipids and biophysical properties in lipoprotein populations. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2026; 779DOI:10.1016/j.abb.2026.110780. PMID:41780664. IF:3.000(Q2/4D).
01/05/2026
Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?
Bellofatto, IA, Nikolaou, PE, Andreadou, I, Canepa, M, Carbone, F, Ghigo, A, Heusch, G, Kleinbongard, P, Maack, C, Podesser, BK, Stamatelopoulos, K, Stellos, K, Vilahur, G, Montecucco, F, Liberale, L. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?. Clinical Research in Cardiology. 2026; 115(5)DOI:10.1007/s00392-024-02522-2. PMID:39167195. IF:3.700(Q1/3D).
01/05/2026
A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden
Dobrosavljevic, M, Landén, M, Brikell, I, Chang, Z, Kuja-Halkola, R, Lichtenstein, P, Andell, P, Andreassen, OA, Bauer, M, Corcoy, R, De Girolamo, G, Reif, A, Larsson, H, Garcia-Argibay, M. A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden. MOLECULAR PSYCHIATRY. 2026; 31(5)DOI:10.1038/s41380-025-03381-7. PMID:41420114. IF:10.100(Q1/1D).
01/05/2026
Lipid prevention in type 1 diabetes: From estimated risk to cumulative risk
Miñambres, I, Pérez, A. Lipid prevention in type 1 diabetes: From estimated risk to cumulative risk. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2026.500894. PMID:41690856. IF:(Q/D).
01/05/2026
Prevalence of germline variants in USP8, USP48, CABLES1 and PAM in patients with pituitary adenomas
de Lapiscina, IM, Baquero, C, Santos, A, Molina, AR, Moure, MD, Aramburu, M, Bancalari, R, Boronat, M, Bueno, G, Casano-Sancho, P, Fernandez-Ramos, C, Garcia-Garcia, E, Gonzalez, A, Gonzalez-Rivera, N, Guerrero-Fernandez, J, Hernandez, MI, Paja, M, Portillo, N, Rica, I, Soto-Moreno, A, Suarez-Ortega, L, Vela, A, Castaño, L, Valdes, N. Prevalence of germline variants in USP8, USP48, CABLES1 and PAM in patients with pituitary adenomas. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2026; 194(5)DOI:10.1093/ejendo/lvag074. PMID:42045809. IF:5.200(Q1/2D).
01/05/2026
Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study
Garcia-Pagan, JC, Gluud, LL, Mandorfer, M, Schattenberg, JM, De Gottardi, A, Berzigotti, A, Fortea, JI, Martínez, AA, Alvarado-Tapias, E, Berning, M, Petryszyn, P, Henricson, E, Berglind, N, Lin, M, Persson, K, Mercier, A, Ambery, P, Bosch, J, Oscarsson, J, Rockey, DC. Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 92(5)DOI:10.1002/bcp.70332. PMID:41362018. IF:3.000(Q2/4D).
01/05/2026
Antithrombotic and management of small bowel bleeding - time to throw caution into the wind?
Scaramella, L, Cosenza, A, Romero-Mascarell, C, Elli, L. Antithrombotic and management of small bowel bleeding - time to throw caution into the wind?. CURRENT OPINION IN GASTROENTEROLOGY. 2026; 42(3)DOI:10.1097/MOG.0000000000001160. PMID:41700996. IF:2.500(Q2/5D).
01/05/2026
Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort
Izarra, A, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro-Boqué, E, Fernández, E, Simó, R, Hernández, C, Lecube, A. Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort. DIABETES OBESITY & METABOLISM. 2026; 28(5)DOI:10.1111/dom.70560. PMID:41705635. IF:5.700(Q1/2D).
01/05/2026
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration
Dingemans, AMC, Opitz, I, Brunelli, A, Remon, J, Hendriks, LE, Edwards, J, Faivre-Finn, C, Reguart, N, Smit, EF, Levy, A, Sanchez-Lorente, D, Trujillo, JC, Filippi, AR, Stathopoulos, K, Blum, TG, Guckenberger, M, Popat, S, De Angelis, R, Hofman, P, von der Thüsen, J, Hartemink, KJ, Petersen, RH, Ruffini, E, Dickhoff, C, Houda, I, Prisciandaro, E, De Ruysscher, D, Derks, J, Bahce, I, Mariolo, A, Besse, B, Xenophontos, E, Levra, NG, van Schil, P, Brandao, M, Berghmans, T. Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration. Lancet Respiratory Medicine. 2026; 14(5)DOI:10.1016/S2213-2600(26)00051-2. PMID:41895314. IF:32.800(Q1/1D).
01/05/2026
Characterizing early behavioral and social-emotional problems in young children with SCN1A+Dravet syndrome: Findings from the ENVISION prospective natural history study
Scheffer, IE, Perry, MS, Sullivan, J, Boronat, S, Wheless, J, Brunklaus, A, Laux, L, Patel, AD, Roberts, C, Dlugos, D, Holder, D, Knupp, K, Lallas, M, Phillips, S, Segal, E, Lal, D, Wirrell, E, Zuberi, SM, Shaffer, R, Wojnaroski, M, Berl, MM, Christensen, S, James, ES, Vila, MC, Huang, N, Gofshteyn, JS, Rico, S. Characterizing early behavioral and social-emotional problems in young children with SCN1A+Dravet syndrome: Findings from the ENVISION prospective natural history study. EPILEPSIA. 2026; 67(5)DOI:10.1002/epi.70127. PMID:41627953. IF:6.600(Q1/1D).
01/05/2026
Ultrastructural analysis of transjugular biopsies in metabolic dysfunction-associated steatotic liver disease identifies core hepatocellular stress adaptations
Ibañez-Samaniego, L, Alonso, S, Cagigal, ML, Catalina, MV, Rodriguez, DR, Peligros, MI, Puente, A, Collado, AS, Téllez, L, Herrera, EL, Alvarado-Tapias, E, Iruzubieta, P, Loste, MTA, Fabrega, E, Cuadrado, A, Lafarga, M, Fortea, J. Ultrastructural analysis of transjugular biopsies in metabolic dysfunction-associated steatotic liver disease identifies core hepatocellular stress adaptations. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Glucagon-like peptide-1 receptor agonists reduce the risk of decompensation in patients with type 2 diabetes across different stages of liver disease
Fajol, MC, Brujats, A, Poca, M, Villanueva, C, Bataller, R, Gomariz, V, Ferrero, A, Alvarado-Tapias, E. Glucagon-like peptide-1 receptor agonists reduce the risk of decompensation in patients with type 2 diabetes across different stages of liver disease. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Long-term outcomes of compensated cirrhosis with mild portal hypertension
Huerta, A, Brujats, A, Alvarado-Tapias, E, Pons, M, Téllez, L, Ojeda, A, Aracil, C, Amezcua, AG, Torres, F, Garcia-Pagán, JC, Albillos, A, Genesca, J, Escorsell, A, Bosch, J, Villanueva, C. Long-term outcomes of compensated cirrhosis with mild portal hypertension. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Myeloid-specific ST6Gal1 deficiency favours atherosclerotic progression
Galvez, CM, Blanco-Colio, L, Picatoste, B, Ortega-Villanueva, L, Mendez-Barbero, N, Oller-Pedrosa, J, Escola-Gil, JC, Bellis, S, Rabinovich, G, Martin-Ventura, JL. Myeloid-specific ST6Gal1 deficiency favours atherosclerotic progression. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.157. PMID:. IF:13.300(Q1/1D).
01/05/2026
Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1 A Multicenter Study
Alen, A, Muñoz, C, Soriano-Amores, M, de Frutos, F, Báez-Ferrer, N, Peña-Peña, ML, Villacorta, E, Ripoll-Vera, T, Zorio, E, Martínez-Gimeno, A, Bermúdez-Jiménez, J, Limeres, J, Tiron, C, Martínez-Alvarez, E, Cabrera-Romero, E, García-Pavía, P, Espinosa, MA, Piqueras, J, García-Hernández, S, Palomino-Doza, J, Moliner-Abós, C, Moris, G, Carrillo-Mora, LM, Syrris, P, Alvarez-Velasco, R, Gimeno, JR, Lorca, R. Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1 A Multicenter Study. JACC-ADVANCES. 2026; 5(5)DOI:10.1016/j.jacadv.2026.102771. PMID:42202377. IF:(Q/D).
01/05/2026
HDL structural and compositional alterations in type 2 diabetes mellitus patients: identifying potential biomarkers for subclinical atherosclerosis detection and disease progression
Martinez, GG, Padro, T, Guala, A, Fernandez, R, Garcia-Elias, A, Borrell-Pages, M, Olivero, R, Martin-Grieve, S, Badimon, L, Maceira, A, Rodriguez-Palomares, JF, Vilahur, G. HDL structural and compositional alterations in type 2 diabetes mellitus patients: identifying potential biomarkers for subclinical atherosclerosis detection and disease progression. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.071. PMID:. IF:13.300(Q1/1D).
01/05/2026
MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis
Chavez, REE, De Isla, LPP, Casanas, MC, Romero, MJR, Badimon, LB, Vilahur, GV, Mata, PM, Padro, TP. MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.002. PMID:. IF:13.300(Q1/1D).